Article in American journal of physiology. Cell physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Minying CuiDivision of Pediatric Neurology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Sebastian EdmanDivision of Pediatric Neurology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-2921-833X
Baptiste JudeDivision of Pediatric Neurology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-5506-2482
Paulo R JannigDivision of Pediatric Neurology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Oscar HorwathDivision of Pediatric Neurology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-3500-2896
Emily ShorterMolecular Muscle Physiology and Pathophysiology Group, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Pieter J KoopmansMolecular Muscle Mass Regulation Laboratory, Department of Health, Human Performance, and Recreation, University of Arkansas, Fayetteville, Arkansas, United States.ORCID 0000-0002-4797-5265
Toby L ChambersMolecular Muscle Mass Regulation Laboratory, Department of Health, Human Performance, and Recreation, University of Arkansas, Fayetteville, Arkansas, United States.ORCID 0000-0001-7567-1819
Ronald G JonesMolecular Muscle Mass Regulation Laboratory, Department of Health, Human Performance, and Recreation, University of Arkansas, Fayetteville, Arkansas, United States.
Abraham NilssonFaculty of Health Science, Department of Orthopedics, Linköping University Hospital, Linköping, Sweden.
Johanna T LannerMolecular Muscle Physiology and Pathophysiology Group, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-1222-9473
Thomas SejersenDivision of Pediatric Neurology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-5961-7097
Eva PonténDivision of Pediatric Neurology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-5228-1914
Kevin A MurachMolecular Muscle Mass Regulation Laboratory, Department of Health, Human Performance, and Recreation, University of Arkansas, Fayetteville, Arkansas, United States.ORCID 0000-0003-2783-7137
Jörg SchilcherFaculty of Health Science, Department of Orthopedics, Linköping University Hospital, Linköping, Sweden.
Ferdinand von WaldenDivision of Pediatric Neurology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-1134-2252
Funding
Mediators of Muscle Rejuvenation with AgingR01AG080047 · NIA · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI Kevin Murach · 2023 to 2026
$2.3M
Mediators of Muscle Rejuvenation with AgingK02AG088465 · NIA · UNIVERSITY OF MISSOURI-COLUMBIA · PI Kevin Murach · 2025 to 2026
$285k
AFM Telethon 23137Åke Wiberg Stiftelse (Åke Wiberg Foundation)Centrum för idrottsforskning (CIF) P2025-0171 & P2024-0102Centrum för idrottsforskning (CIF) P2026-0203China Scholarship Council (CSC)Forskningsrådet i Sydöstra Sverige (FORSS) FORSS-852501Health@InnoHK programHHS | NIH | National Institute on Aging (NIA) AG080047 and AG088465Knut och Alice Wallenbergs Stiftelse (kawforskning)Linnéa and Josef Carlsson foundationNIA NIH HHS K02 AG088465NIA NIH HHS R01 AG080047Östergötland County council RÖ-19969530Stockholm läns landsting (Stockholm County Council)Svenska Sällskapet för Medicinsk Forskning (SSMF) PG-24-0429Vetenskapsrådet (VR) 2022-01392
6 · The paper itself
Abstract
Skeletal muscle repair requires coordinated regulation of inflammation and protein synthesis, but the roles of ribosome biogenesis and protein composition remain poorly defined. To address this, mice underwent femoral artery ligation (FAL) to induce muscle regeneration over 28 days. In humans, tibialis anterior biopsies from patients with traumatic tibial fracture were subjected to RNA sequencing. Following FAL, c
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Ribosome dynamics during skeletal muscle repair and regeneration in mice and humans. · full record | Socratic